- Home
- SNX vs KTTA Comparison
SNX vs KTTA Comparison
Compare SNX & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- KTTA
- Stock Information
- Founded
- SNX 1980
- KTTA 2020
- Country
- SNX United States
- KTTA United States
- Employees
- SNX N/A
- KTTA N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- SNX Technology
- KTTA Health Care
- Exchange
- SNX Nasdaq
- KTTA Nasdaq
- Market Cap
- SNX 11.2B
- KTTA 5.5M
- IPO Year
- SNX 2003
- KTTA 2021
- Fundamental
- Price
- SNX $140.21
- KTTA $0.73
- Analyst Decision
- SNX Strong Buy
- KTTA
- Analyst Count
- SNX 9
- KTTA 0
- Target Price
- SNX $140.89
- KTTA N/A
- AVG Volume (30 Days)
- SNX 1.1M
- KTTA 166.4K
- Earning Date
- SNX 06-24-2025
- KTTA 08-12-2025
- Dividend Yield
- SNX 1.26%
- KTTA N/A
- EPS Growth
- SNX 19.95
- KTTA N/A
- EPS
- SNX 8.55
- KTTA N/A
- Revenue
- SNX $60,007,297,000.00
- KTTA N/A
- Revenue This Year
- SNX $3.34
- KTTA N/A
- Revenue Next Year
- SNX $4.55
- KTTA N/A
- P/E Ratio
- SNX $16.39
- KTTA N/A
- Revenue Growth
- SNX 6.60
- KTTA N/A
- 52 Week Low
- SNX $92.23
- KTTA $0.70
- 52 Week High
- SNX $145.10
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- SNX 73.47
- KTTA 36.47
- Support Level
- SNX $134.31
- KTTA $0.70
- Resistance Level
- SNX $138.97
- KTTA $0.76
- Average True Range (ATR)
- SNX 3.57
- KTTA 0.04
- MACD
- SNX 0.87
- KTTA 0.01
- Stochastic Oscillator
- SNX 91.65
- KTTA 21.88
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).